Amakuru

DELHI NSHYA, 22 Kamena

Raporo yagize ati: “Covaxin ya Bharat Biotech ifite agaciro ka 77.8 ku ijana mu kurinda COVID-19, nk'uko imibare yo mu cyiciro cya III yakozwe ku bantu 25.800 bitabiriye amahugurwa mu Buhinde.”

Igipimo cy’ibikorwa cyagaragaye ku wa kabiri nyuma y’uko komite ishinzwe impuguke mu bijyanye n’ibiyobyabwenge (DCGI) ishinzwe kugenzura ibiyobyabwenge mu Buhinde (SEC) iterana ikaganira ku byavuyemo.

Uruganda rwa farumasi rwashyikirije DCGI amakuru yicyiciro cya gatatu cyikigereranyo muri wikendi.

Raporo zavuze ko biteganijwe ko iyi sosiyete izagirana inama n’ubuyobozi bw’umuryango w’abibumbye ryita ku buzima ku isi ku wa gatatu, kugira ngo baganire ku mabwiriza yo gutanga amakuru n’inyandiko zisabwa.

Ubuhinde bwatangiye gukingira imbaga COVID-19 ku ya 16 Mutarama butanga inkingo ebyiri zakozwe mu Buhinde, ari zo Covishield na Covaxin.

Ikigo cya Serum cyo mu Buhinde (SII) kirimo gukora Covishield ya kaminuza ya AstraZeneca-Oxford, naho Bharat Biotech ifatanya n’inama y’ubuvuzi y’Ubuhinde (ICMR) mu gukora Covaxin.

Urukingo rwa Sputnik V rwakozwe n'Uburusiya narwo rwatangijwe muri iki gihugu. Enditem